Orlando, Fla. – The largest risk-directed study by a nationwide health center system demonstrates a 40 percent decline in bleeding events for percutaneous coronary intervention (PCI) clients and a significant decrease in drug store expenses. This quality enhancement task (QIP) research existed today as a late-breaking medical trial at the Society for Cardiovascular Angiography and Interventions (SCAI) 2016 Scientific Sessions in Orlando, Fla. PCI opens slim or obstructed coronary arteries. While it is a common non-surgical treatment, PCI-related bleeding can result in considerable morbidity and death. The QIP research study intended to lower these bleeding events by using the National Cardiovascular Data Registry (NCDR) bleeding risk calculator and applying it to evidence-based bleeding avoidance str …
< a href=http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=9E6558A7132F47CE9E666AF1C7CBC164&url=http%3a%2f%2fwww.eurekalert.org%2fpub_releases%2f2016-05%2fsfca-nhs050316.php&c=hXAJWznrf00s4gNV9kcKizI8mbCtSxqh61aYD8PAhas&mkt=en-gb target="_ blank
< a href=http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=9E6558A7132F47CE9E666AF1C7CBC164&url=http%3a%2f%2fwww.cmaj.ca%2fcontent%2fearly%2f2016%2f05%2f02%2fcmaj.151201&c=m2on-IR6BdhdWPzRpDIqp-nvwiYHBdjZHCBRTzOWuB0&mkt=en-gb target="_ blank
< a href=http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=9E6558A7132F47CE9E666AF1C7CBC164&url=http%3a%2f%2fwww.biopharmadive.com%2fnews%2fclinical-trials-informatics%2f418121%2f&c=wfQQnWe9YB0LFn7Y0UyG2f9orQOCT0d_b_c3Vbv7s1o&mkt=en-gb target="_ blank
Details contained on this page is supplied by an independent third-party content company. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or remarks about this page please contact [email protected]. SOURCE Sanofi – Collaborations Will Work towards Anticipating Medication Adherence – BRIDGEWATER, N.J., April 27, 2016/ PRNewswire/– Sanofi US announced today partnerships with the Duke Medical Research Institute (DCRI) and, separately, with the Center for Evaluation Technology and Constant Health (CATCH) at Massachusetts General Medical facility. The partnerships are created to develop brand-new tools that will help forecast how people coping with type 2 diabetes stick to their medication. “The DCRI’s collabora …
< a href=http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=9E6558A7132F47CE9E666AF1C7CBC164&url=http%3a%2f%2fwww.kait8.com%2fstory%2f31830753%2fsanofi-us-collaborates-with-duke-university-and-massachusetts-general-hospital-on-big-data-and-type-2-diabetes&c=dlUEyblngwKYwFHw-SgLbNOt-uTsFFdm2a_6jpuSm48&mkt=en-gb target="_ blank
Perioperative Rosuvastatin in Heart Surgery Our apologies. An error happened while setting your user cookie. Please set your internet browser to accept cookies to continue. NEJM.org uses cookies to improve efficiency by remembering your session ID when you browse from page to page. This cookie shops just a session ID; no other information is captured. Accepting the NEJM cookie is needed to utilize the website …
< a href=http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=9E6558A7132F47CE9E666AF1C7CBC164&url=http%3a%2f%2fwww.news-medical.net%2fnews%2f20160504%2fAnaesthesia-services-given-seal-of-approval-by-Royal-College.aspx&c=W2uUJIeorpLeI1wWeYsu-SyAu2JYB8k7ODjwomSNtd4&mkt=en-gb target="_ blank
See all stories on this topic